Health Care & Life Sciences » Biotechnology | Kuros Biosciences Ltd.

Kuros Biosciences Ltd. | Balance Sheet

Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
39,847.00
16,935.00
15,940.00
12,369.00
16,673.00
18,334
Total Accounts Receivable
349.00
120.00
169.00
716.00
351.00
627
Inventories
-
-
-
-
220.00
547
Other Current Assets
141.00
496.00
62.00
311.00
392.00
325
Total Current Assets
40,337.00
17,551.00
16,171.00
13,396.00
17,636.00
19,833
Net Property, Plant & Equipment
93.00
-
3.00
45.00
630.00
634
Total Investments and Advances
72.00
80.00
15.00
15.00
-
-
Intangible Assets
-
-
-
30,312.00
67,777.00
65,354
Other Assets
-
-
-
-
38.00
-
Total Assets
40,502.00
17,631.00
16,189.00
43,768.00
87,421.00
87,639
ST Debt & Current Portion LT Debt
-
37,592.00
3,695.00
-
-
Accounts Payable
1,492.00
152.00
1,019.00
1,273.00
1,320.00
Other Current Liabilities
4,318.00
6,107.00
429.00
1,992.00
3,336.00
Total Current Liabilities
5,810.00
43,851.00
5,143.00
3,265.00
4,656.00
Long-Term Debt
37,297.00
9,830.00
-
-
-
Provision for Risks & Charges
2,995.00
-
606.00
2,181.00
1,688.00
Deferred Taxes
-
-
-
-
6,597.00
Total Liabilities
46,102.00
53,681.00
5,749.00
5,446.00
14,281.00
Common Equity (Total)
5,600.00
36,050.00
10,440.00
38,322.00
73,140.00
Total Shareholders' Equity
5,600.00
36,050.00
10,440.00
38,322.00
73,140.00
Total Equity
5,600.00
36,050.00
10,440.00
38,322.00
73,140.00
Liabilities & Shareholders' Equity
40,502.00
17,631.00
16,189.00
43,768.00
87,421.00

About Kuros Biosciences

View Profile
Address
Wagistrasse 25
Schlieren Zurich 8952
Switzerland
Employees -
Website http://www.kurosbiosciences.com
Updated 07/08/2019
Kuros Biosciences Ltd. engages in the development of products for tissue repair and regeneration. Its products include sealants for tissue restore and orthobiologics for bone healing. The company was founded by Didier Cowling and Jason Schense in 2000 and is headquartered in Schlieren, Switzerland.